NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease

CompletedPhase 3

Sponsor: University Hospital, Bordeaux

Conditions: Alzheimer's Disease

Interventions: Standard intervention protocol, Standard intervention protocol + Cognitive training therapy, Standard intervention protocol + Reminiscence therapy, Standard intervention protocol + "Made-to-measure" program

Countries: France

ETNA3 is a multicentric randomised clinical trial conducted in France to evaluate the impact of cognitive training, reminiscence therapy and a "made-to-measure" program on the progression rate of dementia.

Eligibility overview

Sex: ALL

Age: 50 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Patients in the mild to moderate stages of Alzheimer's Disease : MMSE score between 16 and 26 ; and stages 3 to 5 of the Global Deterioration Scale
* Patients over 50 years of age
* Patients with social security affiliation

Exclusion Criteria:

* Patients suffering other type of dementia
* Institutionalized patients
* Patients with psychiatric disorder
* Patients with severe pathology in the terminal stages
* Patients receiving non pharmacological therapies other than that proposed in the study
* Enrollment in a pharmacological trial in the first 6 months

Locations (39)

Agen, France
Amiens, France
Bordeaux, France
Bordeaux, France
Caen, France
Colmar, France
Dax, France
Draveil, France
Gap, France
Gradignan, France
Grenoble, France
La Rochelle, France
La Seyne-sur-Mer, France
Libourne, France
Limoges, France
Longjumeau, France
Lorient, France
Malestroit, France
Marseille, France
Montpellier, France
Montpellier, France
Nantes, France
Nice, France
Paris, France
Paris, France
Pau, France
Pau, France
Pessac, France
Poissy, France
Poitiers, France
+ 9 more on CT.gov